News
Tango Therapeutics press release (NASDAQ:TNGX): Q2 GAAP EPS of -$0.28 beats by $0.03. Revenue of $5.78M (-68.2% Y/Y) beats by $0.12M. Recommended For You ...
Wall Street expects a year-over-year decline in earnings on lower revenues when Tango Therapeutics, Inc. (TNGX) reports results for the quarter ended June 2025. While this widely-known consensus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback